Login / Signup

Mandibular advancement device therapy in patients with epiglottic collapse.

Eli Van de PerckMarijke DieltjensAnneclaire V VroegopJohan VerbraeckenMarc J BraemOlivier M Vanderveken
Published in: Sleep & breathing = Schlaf & Atmung (2022)
The presence of epiglottic collapse during DISE does not impair the effectiveness of MAD. Therefore, MAD therapy should be considered in patients with predominant epiglottic collapse.
Keyphrases
  • randomized controlled trial
  • systematic review
  • stem cells